{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-229437","form_type":"8-K","ticker":"CADL","cik":"0001841387","company_name":"Candel Therapeutics, Inc.","filed_at":"2021-07-30T23:59:59+00:00","discovered_at":"2026-05-14T18:04:20.066276+00:00","generated_at":"2026-06-30T00:30:59.433496+00:00","sec_items":["5.02","5.03","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Candel appoints Diem Nguyen to board; adopts amended charter and bylaws upon IPO","bullets":["Diem Nguyen appointed to newly created board vacancy, effective July 26, 2021, as Class III director.","Nguyen is independent and will receive standard non-employee director compensation.","Restated certificate authorizes 150M shares of common stock and 10M shares of undesignated preferred.","Amended bylaws eliminate stockholder action by written consent and set procedures for proposals and nominations."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-229437","json":"https://secwatch.observer/filing/0001193125-21-229437.json","markdown":"https://secwatch.observer/filing/0001193125-21-229437.md","text":"https://secwatch.observer/filing/0001193125-21-229437.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1841387/000119312521229437/0001193125-21-229437-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1841387/000119312521229437/d203496d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T00:30:59.433496+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1a7a7a6057","claim":"Diem Nguyen was appointed as Director at Candel Therapeutics, Inc..","evidence_excerpt":"On July 12, 2021, the Board of Directors (the “Board”) of Candel Therapeutics, Inc. (the “Company”) unanimously appointed Diem Nguyen, Ph.D. to fill a newly created vacancy on the Board","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1841387/000119312521229437/0001193125-21-229437-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"ff3a4d886f","claim":"Carrie Cox resigned as Director at Candel Therapeutics, Inc..","evidence_excerpt":"resulting from the resignation of Carrie Cox from the Board","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1841387/000119312521229437/0001193125-21-229437-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}